文献速递流行病学与生物统计真实世界研究与卫生经济

评估电子健康记录在临床试验基线特征与临床结局确认中的适用性:VESALIUS EHR 示范项目见解

Evaluating fitness-for-use of electronic health records in ascertaining baseline characteristics and clinical outcomes in clinical trials: insights from the VESALIUS EHR demonstration project.
PubMed 文献 · Trials · 2026-04-25

VESALIUS-CV 试验嵌入研究纳入 75 名参与者(9 个中心),比较 EHR 与病例报告表(CRF)在基线人口学、实验室及结局数据上的一致性。分类基线变量总体一致率 81.3–98.7%,结局事件总体一致率 86.7–100%,但外周动脉疾病史阳性预测值仅 23.1%。EHR 数据有望减轻试验数据收集负担,但需优化提取与准确性。

要点

  • EHR 与 CRF 在多数分类基线变量和结局事件上总体一致率较高。
  • 外周动脉疾病史识别阳性预测值仅 23.1%,准确性差。
  • 连续变量偏差低但精确度中等,95.8% 病例完全匹配。

核心结论

  • EHR 数据有潜力促进临床试验数据收集并减轻负担,但需进一步优化数据提取和提高准确性。

研究设计与样本

  • VESALIUS-CV 试验嵌入研究,纳入 75 名参与者(9 个中心),比较 EHR 与 CRF 数据的一致性。

主要发现

  • 分类基线变量总体一致率 81.3–98.7%,敏感度 42.9–100%,特异度 50.0–100%,kappa 0.2–0.8。
  • 外周动脉疾病史阳性预测值 23.1%。
  • 431 个连续变量偏差普遍较低但精确度中等,95.8% 病例完全匹配。
  • 20 个结局事件总体一致率 86.7–100%,敏感度 50–100%,特异度 86.7–100%,kappa 0.7–1.0。

临床怎么用

  • EHR 数据可用于辅助临床试验基线特征和结局确认,但需针对特定变量(如外周动脉疾病史)谨慎验证。

局限性

  • 研究仅纳入 75 名参与者和 9 个中心,样本量小。
  • 结局事件总数仅 20 个,统计效能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: A tremendous amount of clinical data is collected and stored in electronic health records (EHRs). Whether this data can be harnessed at scale to facilitate clinical trial conduct remains to be seen. METHODS: The Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke (VESALIUS-CV) trial included an embedded study evaluating the fitness-for-use of EHR data to ascertain baseline demographics (age, sex, race/ethnicity, history of coronary disease, cerebrovascular disease, peripheral artery disease, heart failure, diabetes, hypertension, and atrial fibrillation), laboratory (creatinine, lipid values), and outcomes (myocardial infarction, stroke, revascularization, and heart failure) data, compared to trial data collected through a study case report form (CRF). These are described using concordance statistics (overall agreement, sensitivity, specificity, negative predictive value, positive predictive value, kappa statistic and bias). RESULTS: The VESALIUS-CV EHR substudy included 75 participants (9 sites). For categorical baseline variables, the overall agreement between EHR and CRF data ranged between 81.3 and 98.7%, sensitivity ranged between 42.9 and 100%, specificity ranged between 50.0 and 100%, and kappa statistic ranged between 0.2 and 0.8. Identification of a history of peripheral artery disease in EHR data was poor (positive predictive value 23.1%). Of 431 continuous variables, bias was generally low but was associated with moderate imprecision, with exact matches observed in 95.8% of cases. Of a total of 20 outcome events, the overall agreement ranged between 86.7 and 100%, sensitivity ranged between 50 and 100%, specificity ranged between 86.7 and 100%, and kappa statistic ranged between 0.7 and 1.0. CONCLUSION: EHR data has the potential to facilitate and reduce the burden of data collection for clinical trials, but further work is required to optimize data extraction and improve accuracy.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Gouda P, Nelson AJ, Raman SR, et al. Evaluating fitness-for-use of electronic health records in ascertaining baseline characteristics and clinical outcomes in clinical trials: insights from the VESALIUS EHR demonstration project. Trials. 2026. PMID: 42032789. doi:10.1186/s13063-026-09683-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。